Blood Biomarkers for Neurodegeneration

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

114 papers

Active filtersClassification:Core

Showing 85-96 of total 114 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2020CrossrefDirectly related0 citations

Serum neurofilament light in memory clinic practice

Eline A.J. Willemse; Charlotte E. Teunissen; Philip Scheltens; Everard Vijverberg

Dec 1, 2020Alzheimer's & Dementia

2020CrossrefDirectly related0 citations

Alzheimer’s disease: Blood serum circulating microRNAs as diagnostic biomarkers

Abdul‐Mannaan Giles

Dec 1, 2020Alzheimer's & Dementia

2020OpenAlexDirectly related104 citations

Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis

Steffi De Meyer; Jolien Schaeverbeke; Inge M.W. Verberk; Benjamin Gille; Maxim De Schaepdryver; Emma S. Luckett; Silvy Gabel; Rose Bruffaerts; Kimberley Mauroo; Elisabeth H. Thijssen; Erik Stoops; Hugo Vanderstichele; Charlotte E. Teunissen; Rik Vandenberghe; Koen Poesen

Dec 1, 2020Alzheimer s Research & Therapy

2020OpenAlexDirectly related90 citations

Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation

Yanlong Liu; Hui Li; Jian Wang; Qing Xue; Xiaoyu Yang; Yimin Kang; Mengjie Li; Jinzhong Xu; Guohua Li; Cunbao Li; Hui‐Chih Chang; Kuan‐Pin Su; Fan Wang

Oct 2, 2020JAMA Network Open

2020CrossrefDirectly related26 citations

In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease

Jamie Toombs; Henrik Zetterberg

Jan 1, 2020Brain Communications

2019OpenAlexDirectly related369 citations

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

Sebastian Palmqvist; Philip S. Insel; Erik Stomrud; Shorena Janelidze; Henrik Zetterberg; Britta Brix; Udo Eichenlaub; Jeffrey L. Dage; Xiyun Chai; Kaj Blennow; Niklas Mattsson; Oskar Hansson

Nov 11, 2019EMBO Molecular Medicine

2019CrossrefDirectly related6 citations

Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1

Simone Baiardi; Fabio Pizza; Barbara Polischi; Monica Moresco; Samir Abu-Rumeileh; Giuseppe Plazzi; Piero Parchi

Sep 25, 2019Sleep

2019OpenAlexDirectly related475 citations

The endotoxin hypothesis of neurodegeneration

Guy Charles Brown

Sep 13, 2019Journal of Neuroinflammation

2019OpenAlexDirectly related1,396 citations

Neurofilament light chain as a biomarker in neurological disorders

Lorenzo Gaetani; Kaj Blennow; Paolo Calabresi; Massimiliano Di Filippo; Lucilla Parnetti; Henrik Zetterberg

Apr 9, 2019Journal of Neurology Neurosurgery & Psychiatry

2019OpenAlexDirectly related131 citations

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

Isabelle Bos; Stephanie J. B. Vos; Frans Verhey; Philip Scheltens; Charlotte E. Teunissen; Sebastiaan Engelborghs; Kristel Sleegers; Giovanni B. Frisoni; Olivier Blin; Jill Richardson; Régis Bordet; Magda Tsolaki; Julius Popp; Gwendoline Peyratout; Pablo Martínez‐Lage; Mikel Tainta; Alberto Lleó; Peter Johannsen; Yvonne Freund‐Levi; Lutz Frölich; Rik Vandenberghe; Sarah Westwood; Valerija Dobričić; Frederik Barkhof; Cristina Legido‐Quigley; Lars Bertram; Simon Lovestone; Johannes Streffer; Ulf Andréasson; Kaj Blennow; Henrik Zetterberg; Pieter Jelle Visser

Mar 7, 2019Alzheimer s & Dementia

2018OpenAlexDirectly related64 citations

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome

André Strydom; Amanda Heslegrave; Carla M. Startin; Kin Y. Mok; John Hardy; Jürgen Groet; Dean Nižetić; Henrik Zetterberg

Apr 10, 2018Alzheimer s Research & Therapy